Mumbai, September 4, 2007: Tata Consultancy Services (TCS) (BSE: TCS.BO, NSE: TCS.NS), a leading IT services, business solutions and outsourcing firm, and Roche, one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics headquartered in Basel, Switzerland, have announced a partnership to advance Roche’s Global Capacity Building Initiative (GCBI).
This new initiative will provide services to a number of areas in Roche’s development organization, including Clinical Data Management, Clinical Programming, Biostatistics and Drug Safety support. The aim of the collaboration between TCS and Roche is to create a flexible, scalable and high-quality partnership to support the demands of Roche’s increasing drug pipeline.
Jean-Jacques Garaud, Global Head of Pharma Development at Roche, commented: “For Roche, it was key to find the best partner for our GCBI initiative and the collaboration with TCS is the result of an extensive international search. The partnership with TCS will allow us to address the growing operational needs of our development organization and handle the increasing workload.”
GL Telang, Managing Director of Roche India, added: “Roche is pleased to have found a local partner in India, which has the talents and know-how to support the company in this key initiative.”
The partnership with TCS will help Roche leverage the extensive talent pool in India, maximize synergies, and gain ongoing cost and process improvements, while maintaining high quality and service levels.
Located in Mumbai, the GCBI program consists of a team of highly qualified pharmacologists, physicians, biostatisticians, pharmacists and informatics specialists. TCS will be working closely with Roche and contribute its strong domain expertise, talent management skills, flexible operating models, transition capabilities and performance-driven processes to the initiative.
Commenting on the partnership, J Rajagopal, TCS Executive Vice President and Global Head- Life Sciences & Healthcare, said: “The Global Capacity Building Initiative with Roche is another validation of TCS’ strategy to focus on services supporting the drug development processes and the investments made in building our domain competencies in this area. The opportunity to work with Roche will further enhance our capabilities and help us build a long-term relationship with an innovation driven company like Roche.”
“TCS continues to develop a knowledge-based business, leveraging information technology and the highly talented pool of resources in the life sciences space to fulfill unique resource requirements of companies like Roche,” said VK Raman, Head, BPO Services, TCS.
The Life Sciences & Healthcare team at TCS has over 3200 professional including pharmacologists, physicians, biomedical engineers, biostatisticians, ICH/GCP compliance professionals, GxP consultants, PhDs, IT architects, consultants and management graduates who focus on providing the best-in-class IT consulting, solutions and services to Life Sciences and Healthcare customers across the world.
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world’s biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolism and central nervous system. In 2006, sales by the Pharmaceuticals Division totaled CHF 33.3 billion, and the Diagnostics Division posted sales of CHF 8.7 billion. Roche employs roughly 75,000 people worldwide and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai.
Roche’s Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide. Roche commenced operations in the US over 100 years ago, and these operations include research and development centers that conduct leading-edge work in advancing disease detection and treatment. Our diagnostics and pharmaceuticals businesses in the US employ more than 20,000 people and generate approximately $10 billion in sales (including Genentech), accounting for about 40% of the Roche Group’s global annual revenues. For further information, please visit www.roche.com.
About Tata Consultancy Services Ltd (TCS)
Tata Consultancy Services is an IT services, business solutions and outsourcing organization that delivers real results to global businesses, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT and IT-enabled services delivered through its unique Global Network Delivery Model, recognized as the benchmark of excellence in software development. A part of the Tata group, India’s largest industrial conglomerate, TCS has over 94,000 of the world’s best-trained IT consultants in 47 countries. The company generated consolidated revenues of US $4.3 billion for fiscal year ended March 31, 2007 and is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit TCS at www.tcs.com.
Phone: +91 22 6778 9999
Phone: +1 646-313-4594
Phone: +65 6372 4931
Phone: +44 0207 245 1388
Phone: +56 (2) 2511604
For career related enquiries, please contact firstname.lastname@example.org.